Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006 (2006), Article ID 19724, 7 pages
http://dx.doi.org/10.1155/MI/2006/19724
Research Communication

Is the Association Between TNF-α-308 A Allele and DMT1 Independent of HLA-DRB1, DQB1 Alleles?

1Department of Pediatrics, Endocrinology, and Diabetes, Medical University of Silesia, Katowice 40-752, Poland
2Faculty of Automatic Control, Electronic and Computer Science, Silesian University of Technology, Gilwice 44-101, Poland
3Blood Center, Katowice 40-074, Poland

Received 12 January 2006; Revised 25 March 2006; Accepted 5 April 2006

Copyright © 2006 Grażyna Deja et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M J Redondo and G S Eisenbarth, “Genetic control of autoimmunity in type I diabetes and associated disorders,” Diabetologia, vol. 45, no. 5, pp. 605–622, 2002. View at Publisher · View at Google Scholar
  2. D Devendra, E Liu, and G S Eisenbarth, “Type 1 diabetes: recent developments,” British Medical Journal, vol. 328, no. 7442, pp. 750–754, 2004. View at Publisher · View at Google Scholar
  3. G I Bell, S Horita, J H Karam et al., “A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus,” Diabetes, vol. 33, no. 2, pp. 176–183, 1984. View at Google Scholar
  4. M P Marron, L J Raffel, H-J Garchon et al., “Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups,” Human Molecular Genetics, vol. 6, no. 8, pp. 1275–1282, 1997. View at Publisher · View at Google Scholar
  5. J L Davies, Y Kawaguchi, S T Bennett et al., “A genome-wide search for human type 1 diabetes susceptibility genes,” Nature, vol. 371, no. 6493, pp. 130–136, 1994. View at Publisher · View at Google Scholar
  6. L L Field, “Genetic linkage and association studies of type I diabetes: challenges and rewards,” Diabetologia, vol. 45, no. 1, pp. 21–35, 2002. View at Publisher · View at Google Scholar
  7. J Nerup, P Platz, O O Andersen et al., “HL-A antigens and diabetes mellitus,” The Lancet, vol. 304, no. 7885, pp. 864–866, 1974. View at Publisher · View at Google Scholar
  8. K S Rønningen, N Keiding, and A Green, “Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes,” Diabetologia, vol. 44, no. suppl 3, pp. B51–B59, 2001, on behalf of Genomic Marker Contributors and the EUORODIAB ACE Study Group. View at Google Scholar
  9. A G Wilson, J A Symons, T L Mcdowell, H O Mcdevitt, and G W Duff, “Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 3195–3199, 1997. View at Publisher · View at Google Scholar
  10. K Hamaguchi, A Kimura, N Seki et al., “Analysis of tumor necrosis factor-a promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese,” Tissue Antigens, vol. 55, no. 1, pp. 10–16, 2000. View at Publisher · View at Google Scholar
  11. A Rabinovitch, “Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation?” Diabetes, vol. 43, no. 5, pp. 613–621, 1994. View at Google Scholar
  12. A Rabinovitch and W L Suarez-Pinzon, “Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus,” Biochemical Pharmacology, vol. 55, no. 8, pp. 1139–1149, 1998. View at Publisher · View at Google Scholar
  13. D L Vaux and R A Flavell, “Apoptosis genes and autoimmunity,” Current Opinion in Immunology, vol. 12, no. 6, pp. 719–724, 2000. View at Publisher · View at Google Scholar
  14. M J Hussain, M Peakman, H Gallati et al., “Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM,” Diabetologia, vol. 39, no. 1, pp. 60–69, 1996. View at Google Scholar
  15. K M Kroeger, K S Carville, L J Abraham et al., “The -308 tumor necrosis factor-a promoter polymorphism effects transcription,” Molecular Immunology, vol. 34, no. 5, pp. 391–399, 1997. View at Publisher · View at Google Scholar
  16. A S Low, I Azmy, N Sharaf, C Cannings, and A G Wilson, “Association between two tumour necrosis factor intronic polymorphisms and HLA alleles,” European Journal of Immunogenetics, vol. 29, no. 1, pp. 31–34, 2002. View at Publisher · View at Google Scholar
  17. A M Uglialoro, D Turbay, P A Pesavento et al., “Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-a gene promoter,” Tissue Antigens, vol. 52, no. 4, pp. 359–367, 1998. View at Google Scholar
  18. H Obayashi, N Nakamura, M Fukui et al., “Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus,” Human Immunology, vol. 60, no. 10, pp. 974–978, 1999. View at Publisher · View at Google Scholar
  19. M Matsushita, N Tsuchiya, T Nakayama et al., “Allele typing of human TNFA 5'-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): linkage disequilibrium with HLA class I and class II genes in Japanese,” Tissue Antigens, vol. 54, no. 5, pp. 478–484, 1999. View at Publisher · View at Google Scholar
  20. D S Monos, M Kamoun, I A Udalova et al., “Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus: linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes,” Human Immunology, vol. 44, no. 2, pp. 70–79, 1995. View at Publisher · View at Google Scholar
  21. C E Whichelow, G A Hitman, I Raafat, G F Bottazzo, and J A Sachs, “The effect of TNFB gene polymorphism on TNF-α and -β secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls,” European Journal of Immunogenetics, vol. 23, no. 6, pp. 425–435, 1996. View at Google Scholar
  22. A Cox, A M Gonzalez, A G Wilson et al., “Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM,” Diabetologia, vol. 37, no. 5, pp. 500–503, 1994. View at Publisher · View at Google Scholar
  23. F Pociot, A G Wilson, J Nerup, and G W Duff, “No independent association between a tumor necrosis factor-α promotor region polymorphism and insulin-dependent diabetes mellitus,” European Journal of Immunology, vol. 23, no. 11, pp. 3050–3053, 1993. View at Google Scholar
  24. A Shtauvere-Brameus, P Dabadghao, I Rumba, and C B Sanjeevi, “Tumor necrosis factor-α allele 2 shows an association with insulin-dependent diabetes mellitus in Latvians,” Annals of the New York Academy of Sciences, vol. 958, pp. 357–361, 2002. View at Google Scholar
  25. World Health Organization, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus,” WHO, 1999.
  26. S A Miller, D D Dykes, and H F Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, p. 1215, 1988. View at Publisher · View at Google Scholar
  27. D Turner, S CD Grant, N Yonan et al., “Cytokine gene polymorphism and heart transplant rejection,” Transplantation, vol. 64, no. 5, pp. 776–779, 1997. View at Publisher · View at Google Scholar
  28. S Schneider, D Roessli, and L Excoffier, “Arlequin ver 2.00: a software for population genetics data analysis,” 2000. Genetics and Biometry Laboratory, University of Geneva, Switzerland.
  29. J Ilonen and H Rejonen, “Special genetic features of populations in Nordic countries as related to risk of IDDM,” Diabetes in the Young, vol. 29, pp. 10–16, 1993. View at Google Scholar
  30. M Krokowski, J Bodalski, A Bratek, C Boitard, and S Caillat-Zucman, “HLA class II-associated predisposition to insulin-dependent diabetes mellitus in a Polish population,” Human Immunology, vol. 59, no. 7, pp. 451–455, 1998. View at Publisher · View at Google Scholar
  31. A Kretowski and I Kinalska, “DQA1 and DQB1 HLA genes as a markers of insulin-dependent diabetes mellitus in the Polish population,” Polskie Archiwum Medycyny Wewnetrznej, vol. 101, no. 3, pp. 205–211, 1999. View at Google Scholar
  32. G Y Deng, N K Maclaren, H-S Huang, L-P Zhang, and J-X She, “No primary association between the 308 polymorphism in the tumor necrosis factor α promoter region and insulin-dependent diabetes mellitus,” Human Immunology, vol. 45, no. 2, pp. 137–142, 1996. View at Publisher · View at Google Scholar
  33. L Bouqbis, O Akhayat, H-J Garchon, F Calafell, and H Izaabel, “TNFA-TNFB haplotypes modify susceptibility to type I diabetes mellitus independently of HLA class II in a Moroccan population,” Tissue Antigens, vol. 61, no. 1, pp. 72–79, 2003. View at Publisher · View at Google Scholar
  34. M J Hussain, J Maher, T Warnock, A Vats, M Peakman, and D Vergani, “Cytokine overproduction in healthy first degree relatives of patients with IDDM,” Diabetologia, vol. 41, no. 3, pp. 343–349, 1998. View at Publisher · View at Google Scholar